PMID: 12593065Feb 21, 2003Paper

Increasing the quantity of lungs for transplantation using high-frequency chest wall oscillation: a proposal

Progress in Transplantation : Official Publication, North American Transplant Coordinators Organization ... [et Al.]
Jane M Braverman

Abstract

The use of chest physiotherapy in donor patient management occupies an established place in most lung procurement protocols. Although its merits remain controversial and uncorroborated by direct data, some studies support the efficacy of chest physiotherapy in a variety of pulmonary patient populations. Comparative studies have shown that an airway clearance technology utilizing high-frequency chest wall oscillation clears pulmonary secretions as well as or better than chest physiotherapy, but has few of its contraindications and disadvantages. The implementation of high-frequency chest wall oscillation as part of the donor lung procurement protocol may increase rates of successful lung recovery by providing effective clearance of obstructing pulmonary secretions containing destructive by-products of inflammation and entrapped pathogens. High-frequency chest wall oscillation may also improve arterial blood gas values, a critical factor in increasing lung procurement rates. Although speculative, the benefits of high-frequency chest wall oscillation on donor lungs might improve perfusion and oxygenation of other organs for possible transplantation.

References

Oct 28, 1976·The New England Journal of Medicine·M NewhouseJ Bienenstock
Nov 11, 1991·The Annals of Thoracic Surgery·T M EganB R Wilcox
Apr 1, 1988·British Journal of Diseases of the Chest·P P Sutton
Jul 1, 1986·British Journal of Diseases of the Chest·D C CurrieP J Cole
Feb 2, 1970·JAMA : the Journal of the American Medical Association·M Stein, E L Cassara
Nov 1, 1983·British Journal of Anaesthesia·C G MorranC S McArdle
Feb 1, 1981·Physical Therapy·W E Hammon, R J Martin
Jun 1, 1995·The Journal of Thoracic and Cardiovascular Surgery·S SundaresanG A Patterson
Mar 1, 1995·American Journal of Respiratory and Critical Care Medicine·J ThomasD Brooks
Oct 1, 1994·American Journal of Respiratory and Critical Care Medicine·R ArensM S Woo
Dec 1, 1993·The Annals of Thoracic Surgery·S SundaresanJ D Cooper
Jul 1, 1996·The Annals of Thoracic Surgery·M C MauneyC G Tribble
Oct 1, 1996·Pediatric Pulmonology·J KluftR J Fink
Feb 1, 1996·AORN Journal·H Lloyd-JonesS R Large
Jun 1, 1997·Clinics in Chest Medicine·A E Frost
Jun 1, 1997·Clinics in Chest Medicine·C R Gross, G Raghu
Jun 1, 1997·American Journal of Surgery·F L GroverM Ochs
Aug 1, 1997·Critical Care Medicine·K HoriuchiC Weissman
Dec 11, 1997·The British Journal of Surgery·M Fagevik OlsénK Lundholm
Mar 24, 1998·Annual Review of Medicine·F H Bach
Jan 1, 1997·British Medical Bulletin·C Wight, B Cohen
Jun 25, 1998·Disability and Rehabilitation·S A Prasad, E Main
Sep 4, 1998·Journal of Paediatrics and Child Health·B M ButtonP D Phelan
Mar 23, 1999·Archives of Disease in Childhood·C Wallis, A Prasad
Jul 3, 1999·World Journal of Surgery·D H JenkinsC W Schwab
Jul 22, 1999·The European Respiratory Journal·E HoutmeyersM Decramer

❮ Previous
Next ❯

Citations

Oct 13, 2004·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Marc de PerrotShaf Keshavjee
Nov 5, 2005·AACN Clinical Issues·Richard Arbour
Sep 26, 2008·Journal of Intensive Care Medicine·Joseph DuBose, Ali Salim
May 6, 2006·Tissue Engineering·Ali SamadikuchaksaraeiAnne E Bishop

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.